Ortho Evra Patch Side Effects and Lawsuits


Related Ads

The Ortho Evra Patch is a skin patch used as a contraceptive device to prevent pregnancy in women.  The device couples two forms of hormones, progestin and estrogen, in order to create a hormonal contraceptive method.  The Ortho Evra Patch has been under ongoing scrutiny from the FDA and consumer advocates for a number of issues, which are most notably related to the high levels of estrogen the patch leaves in women’s systems during use.  According to the FDA, Ortho Evra Patch wearers face having estrogen levels at sixty percent higher than users of other birth control oral pill varieties.  The main fear behind the increased levels of estrogen is the well-known links between high estrogen exposure and blood clots.

Risks and Symptoms of Ortho Evra Patch

Users of the Ortho Evra patch consistently experience levels of estrogen much higher than those of the normal population and those taking oral forms of contraceptives.  Additionally, the risks of increased estrogen levels leave patients vulnerable to blood clotting.  Furthermore, smokers and older users of the patch are at risk for high levels of blood and heart vessel complications.  The makers of Ortho Evra Patches have incurred several mandates from the FDA regarding the marketing of the product, with the first being in 2005 stating the label of the prescription needed to alert users to the increased estrogen levels.  Further FDA intervention required the drug in late 2006 to contain strong warning labels regarding the increased risk of blood clotting from using the patch.

Ortho Evra Patch Claims and Lawsuits

Currently, the drug is still available for consumer use with prescription.  These prescriptions of Ortho Evra require terse warning labels affixed to the drug.  Class action litigation against the makers of Ortho Evra Patches, Ortho-McNeil Pharmaceuticals, has already begun in the federal courts as of March 2006.  The class action suit alleges product liability claims against Ortho-McNeil, including marketing a defective product, failure to warn consumers of the risk, and designing a defective product.  The case has already attracted over seventy plaintiffs with more expected.  Additionally, a wrongful death claim stemming from Ortho Evra Patch use causing a fatal pulmonary embolism in a twenty-year woman has been filed against the company.

Legal Help from a Lawyer

Women or the loved ones of a deceased woman’s estate should immediately consult with an attorney if they have been taking Ortho Evra in patch form, while experiencing estrogen related medical issues, including blood clotting causing stroke, heart attack, and other life-threatening medical situations.  An attorney can guide clients into the appropriate legal forum to voice their damage claims and ensure their rights to compensation from settlement or judgment awards from Ortho-McNeil Pharmaceuticals, which are the makers of the Ortho Evra Patch.

This article is provided for informational purposes only. If you need legal advice or representation,
click here to have an attorney review your case .
NOLODRUPAL-web1:DRU1.6.12.2.20161011.41205